127 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Mar 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
13
Ending by 2030
Mar 2027
Next term end
115
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jul 2033 · High confidence
Also notable
Ends Sep 2031 · High confidence
Also notable
Ends Jun 2038 · High confidence
Also notable
Ends Jan 2030 · High confidence
Also notable
Ends Sep 2033 · High confidence
Also notable
Ends Apr 2035 · High confidence
Also notable
Ends Dec 2038 · High confidence
Also notable
Ends Jun 2038 · High confidence
Intraocular Lens and Manufacturing Method Thereof
US 9,808,340
Cited by 21 later US patents, top 25% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Knee Joint Supporter
US 9,138,020
The most cited patent in this portfolio, cited by 42 later US patents, top 25% of utility patents granted in 2015 in our data. Protection runs to 2031.
Pemafibrate Dosing Regimens
US 11,554,109
A family of 6 related applications built on the 2023 grant. Protection runs to 2038.
Serial Data Communication System and Serial Data Communication Method
US 8,972,638
Cited by 29 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2030.
Therapeutic Agent for Dyslipidemia
US 9,572,798
The largest patent family in this portfolio, 5 related applications, renewed at every maintenance window due so far. Protection runs to 2033.
Lens Barrel
US 10,295,839
Granted 2019 and renewed at 2 of 3 maintenance windows. Protection runs to 2035.
Methods of Treating Mixed Dyslipidemia and Hypertriglyceridemia
US 11,446,282
Granted 2022. Computed term ends 2038.
Pharmaceutical Composition
US 11,298,340
Granted 2022. Computed term ends 2038.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Dec 4 to 11, 2026 · next Dec 4
- 1 fee due Jan 2, 2027The maintenance fee for Supporter (US 10,335,306) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
- 3 fees due Feb 8 to 22, 2027 · next Feb 8
- 4 fees due Mar 3 to 22, 2027 · next Mar 3
- 4 fees due Apr 1 to 20, 2027 · next Apr 1
- 3 fees due May 5 to 24, 2027 · next May 5
- 1 fee due Jun 17, 2027The maintenance fee for Intraocular Lens Insertion Apparatus (US 10,507,099) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
- 4 fees due Jul 2 to 23, 2027 · next Jul 2
- 1 fee due Aug 25, 2027The maintenance fee for Image Processing Apparatus, Image Processing Method, and Image Processing Program (US 10,573,007) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
- 1 fee due Sep 12, 2027The maintenance fee for Method of Collecting Bagworm Silk Thread (US 11,926,927) comes due Sep 12, 2027. Unpaid by Mar 13, 2028, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Non-Cellular Root Canal Filling Material and Non-Cellular Dental Tissue Regeneration Promoting Kit (US 11,969,487) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
- 1 fee due Nov 12, 2027The maintenance fee for Toric Ophthalmic Lens (US 10,646,328) comes due Nov 12, 2027. Unpaid by May 12, 2028, it lapses early.
Recent changes
- 3 of the patents on this record were granted since Aug 22, 2026
- 2 terms have ended since Aug 22, 2026
- Oct 28 US 8,870,378 Ophthalmic Measurement Device · lapsed on the fee record
- Sep 6 US 7,475,987 Perimeter · term ended
What they patent
The largest of its 115 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Therapeutic Agent for Dyslipidemia | 4 in force | to Sep 2033 |
| Pemafibrate Dosing Regimens | 3 in force | to Sep 2038 |
| Telescope | 2 in force | to Oct 2041 |
| An Apparatus for Producing a Bagworm Silk Thread, and Method of Producing Long Bagworm Silk Thread | 2 in force | to Apr 2040 |
| Pharmaceutical Composition | 2 in force | to Jun 2038 |
| Lens Barrel | 2 in force | to Jun 2035 |
| Solid Preparations Containing Tofogliflozin and Process of Producing the Same | 2 in force | to Dec 2034 |
| Intraocular Lens and Manufacturing Method Thereof | 2 in force | to Jul 2033 |
| Knee Joint Supporter | 2 in force | to Sep 2031 |
| Pharmaceutical Preparation | 1 in force | to May 2043 |
| Multifocal Diffractive Lens | 1 in force | to Mar 2043 |
| Ophthalmic Device | 1 in force | to Feb 2043 |
| Methods of Treating Fuchs Endothelial Corneal Dystrophy After Descemetorhexis | 1 in force | to Jan 2043 |
| Three-Dimensional Measurement Device | 1 in force | to Jan 2043 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,325,925 | Perimeter In force · High confidence | In force | High confidence | |
| US 7,897,397 | Cell Fusion Promoter and Utilization of the Same held by Kowa Company, Ltd., Kitakaze, Masafumi, Minamino, Tetsuo and Hirata, Akio In force · High confidence | In force | High confidence | |
| US 7,475,988 | Perimeter In force · High confidence | In force | High confidence | |
| US 7,658,496 | Perimeter In force · High confidence | In force | High confidence | |
| US D701,317 | Retinal Camera In force · High confidence | In force | High confidence | |
| US D709,199 | Perimeter In force · High confidence | In force | High confidence | |
| US 7,753,525 | Ophthalmic Apparatus In force · High confidence | In force | High confidence | |
| US D742,014 | Pedestal for Handheld Slit Lamp In force · High confidence | In force | High confidence | |
| US 8,972,638 | Serial Data Communication System and Serial Data Communication Method In force · High confidence | In force | High confidence | |
| US 8,557,122 | Ballast Water Treatment Equipment, a Ballast Water Detoxifying Treatment System Using the Same, and a Method for Treating the Ballast Water held by Tohoku University, Kowa Kogyo Co., Ltd., Yamanishi Corporation, Tsuda Kaiun Co., Ltd. and Japan Basic Material Co., Ltd. In force · High confidence | In force | High confidence |
Also on record, not counted in the 127: 4 patents in force now held by others · 167 patents ended · 56 applications pending · 161 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.